Unlike pulmonary anthrax, which occurs due to inhalation of spores, these two types are less aggressive and have minimal chance of human-to-human transmission.

In addition to supporting the development of NUZYRA for both the treatment and prophylaxis of pulmonary anthrax, this contract supports the U.S. onshoring of NUZYRA and manufacturing security ...

In addition to supporting the development of NUZYRA for both the treatment and prophylaxis of pulmonary anthrax, this contract supports the U.S. onshoring of NUZYRA and manufacturing security ...

(RTTNews) - Paratek Pharmaceuticals, Inc. (PRTK) Tuesday announced positive topline efficacy data for Nuzyra as post-exposure prophylaxis (PEP) of pulmonary anthrax in non-human primates (NHPs ...

In addition to supporting the development of NUZYRA for both the treatment and prophylaxis of pulmonary anthrax, this contract supports the U.S. onshoring of NUZYRA and manufacturing security ...

Pulmonary anthrax, the most severe presentation, has initial symptomatology of a common cold but can rapidly progress to severe breathing difficulties and shock.

In addition to supporting the development of NUZYRA for both the treatment and prophylaxis of pulmonary anthrax, this contract supports the U.S. onshoring of NUZYRA and manufacturing security ...

Given the possible severity of anthrax infection, early and fast diagnosis is key. InBios International, Inc., a developer of diagnostic tests for emerging infectious diseases and biothreats, has been ...

“This positive top line data represents further validation of NUZYRA’s potential to treat pulmonary anthrax as well as the continued commitment by BARDA to our ongoing partnership,” said ...